San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Allergan Buys Akarna Therapeutics for $50M

Pharmaceutical giant Allergan Plc has acquired Akarna Therapeutics Inc. for $50 million.

Apricus Biosciences Inc. Plans to Raise $4.6M in Direct Offering of Common Stock

San Diego biopharma Apricus Biosciences Inc. is expected to raise $4.6 million in a direct offering of its common stock to institutional investors, the company said Sept. 23.

Mast Terminates Clinical Development of Sickle Cell Drug Following Poor Results; Co.'s Stock Plunges

The stock of local biotech Mast Therapeutics Inc. has plummeted nearly 80 percent following news of lousy clinical trial results.

Xencor Expanding L.A. County Operations Into San Diego

L.A. County-based Xencor Inc. is expanding its operations into San Diego, the company announced Thursday.

Tease photo

Medicine, Motivation Mix in New Network

Care: Incentives, Employer Participation Part of Coverage

An alternative to conventional health insurance is being marketed to San Diego-area employers with the promise of transparent medical costs, greater focus on physician-managed preventive care and potential savings to be shared by virtually everyone involved.

Cidara Therapeutics' Platform Identifies Potential New Drug Candidate

Local drugmaker Cidara Therapeutics Inc. has identified a new research target that could potentially treat bacterial infections that have formed resistance to multiple drugs on the market, the company said Wednesday.

AMN Healthcare Subsidiary Announces $300 Million Private Offering

A subsidiary of San Diego’s staffing giant AMN Healthcare Services is making a private offering of $300 million in senior notes, according to an AMN news release.

ACA Fund Awards $1.3M to 12 County Health Centers

Twelve San Diego County health centers received a total of more than $1.3 million as part of an $87 million federal investment in health information technology announced Sept. 15 by Health and Human Services Secretary Sylvia M. Burwell.

Tease photo

Unusual Biotech Booster Enjoys Having a Lot on Her Plates

BIOTECH: Restaurateur Serves as Host, ‘Translator’ And Ambassador for Sector

In San Diego’s biotech world, there’s a name that circulates often: Amanda Caniglia, the lively café owner in Torrey Pines who’s shifted from outsider to industry insider.

Tease photo

Plotting The Course

BIOTECH: Co.’s Software, Data Bring Key Information To Choosing Cancer Treatments

The buzz in San Diego is that our software hub is growing, but the city’s true sweet spot is where science and software meet.

Westliving Plans $7 Million Renovation of Oakdale of La Mesa

Carlsbad-based Westliving announced it will spend $7 million to renovate Oakdale of La Mesa, a 180-unit assisted living and memory care facility it bought last year at 5740 Lake Murray Blvd.

Skylit Medical Changes Name to Clarify Medical, Appoints New CEO

San Diego medtech startup Skylit Medical has changed its name to Clarify Medical and brought in local executive James M. Sweeney as its new CEO.

Rady Children’s Hospital, Five Other Medical Centers Form Consortium

Rady Children’s Hospital-San Diego has joined five other pediatric medical centers to form the Sanford Children’s Genomic Medicine Consortium, a collaboration intended to speed the integration of genomic medicine into pediatric care and otherwise support development of new medical treatments and cures for kids.

Tease photo

Ken Song Named President/CEO of Biotech Metacrine Inc.

Metacrine Inc., a new venture launched by biotech bigwigs in San Diego last year, has appointed a new president and chief executive officer: Dr. Ken Song.

Miranda Toledano Chosen to Lead Corporate Development at Sorrento Therapeutics

San Diego’s Sorrento Therapeutics Inc., a public biopharmaceutical firm, has appointed Miranda Toledano as executive vice president of corporate development of Sorrento and president of LA Cell, Sorrento's joint venture with City of Hope.